<DOC>
	<DOCNO>NCT00382824</DOCNO>
	<brief_summary>The clinical syndrome PSP respond poorly available form therapy use Parkinson 's Disease ( PD ) . Currently , effective treatment exists . Coenzyme Q10 high dos show beneficial therapy PD might possibly beneficial therapy PSP . This study compare efficacy , safety tolerability Coenzyme Q10 versus placebo patient atypical parkinsonian syndrome , progressive supranuclear palsy ( PSP ) .</brief_summary>
	<brief_title>Effects Coenzyme Q10 Progressive Supranuclear Palsy ( PSP )</brief_title>
	<detailed_description>The study design multicenter randomize , placebo-controlled , double blind trial . Up 60 patient PSP enrol several center United States</detailed_description>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Parkinsonian Disorders</mesh_term>
	<mesh_term>Supranuclear Palsy , Progressive</mesh_term>
	<mesh_term>Coenzyme Q10</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<criteria>Patients fulfil diagnostic criterion PSP/diagnosed within past 5 year Either vertical supranuclear palsy slow vertical saccade Prominent postural instability fall first year disease onset No evidence disease could explain foregoing feature Current previous therapeutic use CoQ10 Parkinsonism due drug History pallidotomy , thalamotomy , active deep brain stimulator fetal tissue transplant History active epilepsy , stroke , structural brain disease Use methylphenidate hydrochloride , cinnarizine , reserpine , amphetamine , monoamine oxidaseA inhibitor within 3 month baseline visit . Active cancer cancer undergo treatment Participation drug study use investigational drug within 30 day screen . Known hypersensitivity Coenzyme Q10 . Pregnant , plan pregnancy nurse woman</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Progressive Supranuclear Palsy</keyword>
	<keyword>Atypical Parkinsonism</keyword>
	<keyword>CoQ10</keyword>
</DOC>